Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.031 AUD | 0.00% | -3.13% | -24.39% |
Feb. 22 | PharmX Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2024 * | 7.2M 4.69M | Sales 2025 * | 8.7M 5.67M | Capitalization | 18.55M 12.08M |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.21M | Net income 2025 * | - 0 | EV / Sales 2024 * | 2.58 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.99% |
1 week | +3.33% | ||
Current month | -3.12% | ||
1 month | -3.12% | ||
3 months | -24.39% | ||
6 months | -27.91% | ||
Current year | -24.39% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.031 | 0.00% | 1,517,000 |
24-03-27 | 0.031 | +3.33% | 1,072,876 |
24-03-25 | 0.03 | 0.00% | 1,513,396 |
24-03-22 | 0.03 | 0.00% | 75 |
24-03-21 | 0.03 | -6.25% | 2,349,597 |
Delayed Quote Australian S.E., March 27, 2024 at 11:18 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.47% | 360B | |
+24.74% | 266B | |
+25.04% | 163B | |
+21.17% | 106B | |
+7.75% | 77.53B | |
+39.27% | 56.11B | |
+40.44% | 51.6B | |
+10.54% | 39.3B | |
+7.34% | 31.13B |
- Stock
- Equities
- Stock PharmX Technologies Limited
- Stock PharmX Technologies Limited - Australian S.E.